About the Study

Type 1 Diabetes: A study to help preserve remaining insulin secretion

This study is being done for children/adults: • With type 1 Diabetes Diagnosis • Able to wear a Continuous Glucose Monitoring This study is to see if giving the medications rituximab-pvvr (Ruxience®) followed by abatacept can help preserve remaining insulin secretion if given within three months of being diagnosed with type 1 diabetes (T1D).This study will help researchers to learn more about how to help people with diabetes Type 1.

Interested in learning more?

Full Study Name: TN-25 RELAY